Design of Montelukast Nanocrystalline Suspension for Parenteral Prolonged Delivery
Sign Up to like & getrecommendations! Published in 2022 at "International Journal of Nanomedicine"
DOI: 10.2147/ijn.s375888
Abstract: Background Montelukast (MTK), a representative leukotriene receptor antagonist, is currently being investigated as a potential candidate for treating Alzheimer’s disease. For potent and effective dosing in elderly patients, a parenteral prolonged delivery system is favored,… read more here.
Keywords: nanocrystalline suspension; prolonged delivery; mtk; delivery ... See more keywords